Matthew Ericksen, DO
Otolaryngology/Facial Plastic Surgery · Bolivar, MONPI 1285956797
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 64 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by Sanofi at 31.9% of the total.
Across 64 payments — averaging $28.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$572
- Inspire Medical Systems, Inc.$421
- Regeneron Healthcare Solutions, Inc.$377
- Acclarent, Inc$91
- Intersect ENT, Inc.$80
- Optinose US, Inc.$71
- plus $181 from 7 others
What the payments were for
- Food & beverage$1,793100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 22 | $572 |
| Inspire Medical Systems, Inc. | 7 | $421 |
| Regeneron Healthcare Solutions, Inc. | 15 | $377 |
| Acclarent, Inc | 3 | $91 |
| Intersect ENT, Inc. | 4 | $80 |
| Optinose US, Inc. | 3 | $71 |
| GSK | 2 | $44 |
| Medtronic | 2 | $43 |
| Smith+Nephew | 2 | $31 |
| Kaleo, Inc. | 1 | $18 |
| Stryker | 1 | $17 |
| Phadia US Inc. | 1 | $15 |
| Alk-abello, Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$200
How this compares
Too few otolaryngology/facial plastic surgery providers in Missourito place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 20 | $83,444 |
| Ipratropium Bromide | 180 | $5,393 |
| Fluticasone Propionate | 255 | $3,445 |
| Fluocinolone Acetonide Oil | 43 | $1,700 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 28 | $1,587 |
| Azelastine Hcl | 43 | $1,469 |
| Mometasone Furoate | 46 | $874 |
| Pantoprazole Sodium | 76 | $614 |
| Doxycycline Hyclate | 39 | $612 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 32 | $339 |
| Ofloxacin | 12 | $330 |
| Famotidine | 17 | $318 |
| Methylprednisolone | 41 | $284 |
| Mupirocin | 16 | $131 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 34 | $117 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology/facial plastic surgery in Bolivar
- Heather CurtisHannibal$57K
- Richard MaackChesterfield$18K
- Brian HendricksKansas City$6K
- Kent McIntireJoplin$987
- Stephen HadfordColumbia$859
- Jonathan BrownSedalia$663
- Kelly BurchettKirksville$554
- Eric BarbariteCreve Coeur$436
- Mark HechlerWarrensburg$326
- Larry McIntireJoplin$220
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.